Sullivan & Cromwell earned Law360’s “Practice Group of the Year” distinction in nine categories, tied for the most of any firm: Banking, Bankruptcy, Capital Markets, Fintech, Life Sciences, Mergers & Acquisitions, Project Finance, Tax and Transportation. The annual awards honor “the attorney teams behind litigation wins and major deals that resonated throughout the legal industry this past year.”
S&C was recognized for advising:
- Abiomed in its $18 billion acquisition by Johnson & Johnson, the largest all-cash medtech deal in history.
- Amgen in its $27.8 billion acquisition of Horizon Therapeutics, which included navigating tax intricacies of the Irish Takeover Code.
- Credit Suisse on its landmark merger with UBS.
- FTX Trading as lead bankruptcy counsel in its Chapter 11 proceedings.
- JPMorgan in its acquisition of fintech firm Aumni, a venture capital investment analytics provider.
- Seagen in its $43 billion acquisition by Pfizer, the largest-ever all-cash change of control in the pharma industry.
- Sempra Infrastructure Partners in its $7 billion project financing of the Port Arthur LNG Phase 1 project and the related sale of a non-controlling interest in the project to KKR.
- SoftBank Group as the majority shareholder in Arm Holdings’ $5.23 billion IPO, the largest IPO of 2023.
- Stellantis in defeating a high-profile RICO suit brought by General Motors.